These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 11972394

  • 21. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E.
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [Abstract] [Full Text] [Related]

  • 22. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
    Levavi H, Neri A, Bar J, Regev D, Nordenberg J, Ovadia J.
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
    [Abstract] [Full Text] [Related]

  • 23. Predictors of low risk of persistent trophoblastic disease in molar pregnancies.
    Niemann I, Petersen LK, Hansen ES, Sunde L.
    Obstet Gynecol; 2006 May; 107(5):1006-11. PubMed ID: 16648403
    [Abstract] [Full Text] [Related]

  • 24. Clinical and laboratory investigation of a virilized woman with placental-site trophoblastic tumor.
    Nagelberg SB, Rosen SW.
    Obstet Gynecol; 1985 Apr; 65(4):527-34. PubMed ID: 2984618
    [Abstract] [Full Text] [Related]

  • 25. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
    Cole LA, Kohorn EI, Kim GS.
    J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
    [Abstract] [Full Text] [Related]

  • 26. A rapid solid-phase radioimmunoassay specific for human chorionic gonadotropin in gestational trophoblastic disease.
    Goldstein DP, Pastorfide GB, Osathanondh R, Kosasa TS.
    Obstet Gynecol; 1975 May; 45(5):527-30. PubMed ID: 164644
    [Abstract] [Full Text] [Related]

  • 27. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
    Cole LA, Butler SA, Khanlian SA, Giddings A, Muller CY, Seckl MJ, Kohorn EI.
    Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
    [Abstract] [Full Text] [Related]

  • 28. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA, Schlaerth JB, Ahn C, Sauer MV.
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [Abstract] [Full Text] [Related]

  • 29. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
    van Cromvoirt SM, Thomas CM, Quinn MA, McNally OM, Bekkers RL.
    Gynecol Oncol; 2014 Jun; 133(3):542-5. PubMed ID: 24631700
    [Abstract] [Full Text] [Related]

  • 30. Androgenetic complete mole coexistent with a twin live fetus.
    Matsui H, Iitsuka Y, Ishii J, Osada H, Seki K, Sekiya S.
    Gynecol Oncol; 1999 Aug; 74(2):217-21. PubMed ID: 10419734
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Serum human chorionic gonadotropin regression pattern in persistent trophoblastic disease during chemotherapy.
    Lertkhachonsuk R, Limpongsanurak S.
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S352-9. PubMed ID: 11529357
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
    Grinevich IuA, Tatarinov IuS, Iugrinova LG, Olefirenko GA, Dotsenko IuS.
    Vopr Onkol; 1981 Jun; 27(12):19-23. PubMed ID: 6275607
    [Abstract] [Full Text] [Related]

  • 35. Laboratory assessment of disappearance patterns of human chorionic gonadotropin from serum of patients with gestational trophoblastic disease.
    Boots LR, Hatch KD, Younger JB.
    Ala J Med Sci; 1983 Oct; 20(4):391-4. PubMed ID: 6316799
    [No Abstract] [Full Text] [Related]

  • 36. New criteria for the diagnosis of gestational trophoblastic disease.
    Romero R, Horgan JG, Kohorn EI, Kadar N, Taylor KJ, Hobbins JC.
    Obstet Gynecol; 1985 Oct; 66(4):553-8. PubMed ID: 2995891
    [Abstract] [Full Text] [Related]

  • 37. [Trophoblastic beta 1-glycoprotein in the blood in trophoblastic tumors].
    Sokolov AV, Zhordaniia KI, Ledian KM.
    Med Radiol (Mosk); 1983 Aug; 28(8):25-31. PubMed ID: 6310307
    [Abstract] [Full Text] [Related]

  • 38. Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.
    Wolfberg AJ, Growdon WB, Feltmate CM, Goldstein DP, Genest DR, Chinchilla ME, Berkowitz RS, Lieberman ES.
    Obstet Gynecol; 2006 Aug; 108(2):393-6. PubMed ID: 16880311
    [Abstract] [Full Text] [Related]

  • 39. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M, el-Shobokshy AS, el-Noury AI.
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [Abstract] [Full Text] [Related]

  • 40. [Molar pregnancy (primary or recurrent?)].
    Ayala A, Aizpuru E, Tovar JM.
    Ginecol Obstet Mex; 1989 Aug; 57():226-8. PubMed ID: 2562106
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.